A new trading day began on Monday, with Alzamend Neuro Inc (NASDAQ: ALZN) stock price up 32.15% from the previous day of trading, before settling in for the closing price of $0.68. ALZN’s price has ranged from $0.64 to $15.06 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 89.05%. With a float of $6.35 million, this company’s outstanding shares have now reached $6.60 million.
The firm has a total of 7 workers. Let’s measure their productivity. In terms of profitability, gross margin is 66.67%, operating margin of -5528.78%, and the pretax margin is -5553.72%.
Alzamend Neuro Inc (ALZN) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Alzamend Neuro Inc is 3.75%, while institutional ownership is 1.72%. The most recent insider transaction that took place on Mar 12 ’25, was worth 68. In this transaction Director of this company bought 100 shares at a rate of $0.68, taking the stock ownership to the 77,368 shares. Before that another transaction happened on Aug 06 ’24, when Company’s Director bought 75 for $2.75, making the entire transaction worth $206. This insider now owns 77,268 shares in total.
Alzamend Neuro Inc (ALZN) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 89.05% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 61.95% during the next five years compared to -11.45% drop over the previous five years of trading.
Alzamend Neuro Inc (NASDAQ: ALZN) Trading Performance Indicators
Here are Alzamend Neuro Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 5.44.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.06, a number that is poised to hit -0.30 in the next quarter and is forecasted to reach -1.22 in one year’s time.
Technical Analysis of Alzamend Neuro Inc (ALZN)
Analysing the last 5-days average volume posted by the [Alzamend Neuro Inc, ALZN], we can find that recorded value of 0.28 million was lower than the volume posted last year of 0.42 million. As of the previous 9 days, the stock’s Stochastic %D was 47.70%. Additionally, its Average True Range was 0.08.
During the past 100 days, Alzamend Neuro Inc’s (ALZN) raw stochastic average was set at 22.98%, which indicates a significant decrease from 89.02% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 133.47% in the past 14 days, which was higher than the 73.18% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.0207, while its 200-day Moving Average is $2.1835. Now, the first resistance to watch is $0.9575. This is followed by the second major resistance level at $1.0201. The third major resistance level sits at $1.1428. If the price goes on to break the first support level at $0.7722, it is likely to go to the next support level at $0.6495. Now, if the price goes above the second support level, the third support stands at $0.5869.
Alzamend Neuro Inc (NASDAQ: ALZN) Key Stats
With a market capitalization of 5.91 million, the company has a total of 6,597K Shares Outstanding. Currently, annual sales are 0 K while annual income is -9,950 K. The company’s previous quarter sales were 0 K while its latest quarter income was -1,360 K.
